GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.25
Bid: 32.00
Ask: 32.50
Change: -0.20 (-0.62%)
Spread: 0.50 (1.563%)
Open: 32.50
High: 32.00
Low: 31.70
Prev. Close: 32.20
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Royalty Agreement

16 Dec 2021 07:00

RNS Number : 8149V
Duke Royalty Limited
16 December 2021
 

16 December 2021

 

Duke Royalty Limited

 

("Duke Royalty" or "Duke")

 

New Royalty Agreement with Specialist Social Care Business

 

Duke Royalty, a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and North America, is pleased to announce that it has entered into a new £10.5 million royalty financing agreement (the "Financing") with Tristone Healthcare Limited ("Tristone"), further broadening its revenue base.

 

Tristone provides specialist residential and domiciliary care in two end markets: i) high acuity adults with severe mental, physical or learning disabilities; and ii) care leavers, aged 16-19, who are transitioning out of social care and into independent living.

 

Highlights:

 

· Initial cash yield of 13.5% per annum via monthly payments, which commence immediately.

· 30-year secured financing, with distributions to be adjusted annually to reflect Tristone's consolidated revenue growth, on typical Duke terms.

· Tristone's subsidiaries have a combined 40 year operating history, and offer a high degree of recurring revenue, with demonstrated organic growth.

· Formed in 2015, Tristone has acquired three specialist care businesses to date, and Duke expects to provide further financing over the next 18 months to fund Tristone's growing pipeline of bolt-on transactions.

· Duke's initial investment will refinance Tristone's existing capital structure.

 

Neil Johnson, CEO of Duke Royalty, said:

 

"Duke Royalty is excited to be entering the UK care space. There is a growing need for high-quality operators in Tristone's end markets and the company has a strong reputation for delivering outstanding support. Our long-term funding helps Tristone grow capacity while removing refinancing risk, so the business can focus on allocating capital towards what matters - best-in-class care for vulnerable people.

 

"We are excited to back its CEO, Yannis, and the Tristone team as a royalty partner because they have a long-term vision, they exemplify social responsibility, and because partnering with Duke aligns with their goals."

 

Yannis Loucopoulos, CEO of Tristone, said:

 

"We were looking for a funding partner that shares our values and vision for building a group of care businesses with a long term, care-centric focus which prioritises delivering outstanding care and support.

 

"The long-term and non-controlling characteristics of this financing was compelling as it enables us to focus on what we do best without any refinancing risk and without having to compromise our values or approach. We look forward to working with the team to deliver our shared ambitions."

 

About Tristone

 

Tristone is committed to the acquisition and growth of social care companies which have proven business models. Tristone deeply understands the demands of social care and support and has extensive experience of investing in and building businesses of this nature, having supported a number of different care businesses since formation in 2015.

 

Tristone's management philosophy is to operate a simple and care-centric community of businesses that focus, first and foremost, on delivering outstanding care and support. Tristone's operating subsidiaries retain their identity and value base, and Tristone aims to help support existing management and staff teams to unlock further growth and value and ultimately positively impact more lives.

 

About the Financing

 

Duke has agreed to provide Tristone with a total investment line of up to £20 million. The remaining £9.5 million will primarily be drawn in the future for the acquisition of additional care homes and for general working capital purposes.

 

The terms of the Financing are broadly in line with Duke's typical investment criteria. The Financing is provided through a secured loan and Duke will be entitled to monthly distributions (the "Distribution") beginning in December 2021.

 

In line with Duke's other investments, and reflective of the participating nature of Duke's business model, the Distribution will be adjusted annually based on the percentage change in Tristone's total gross revenues for the 12 months to 31 March 2022, compared to the prior financial year. The first adjustment will occur from 30 June 2022. The annual adjustment in the Distribution will be subject to an agreed collar, in line with Duke's typical terms.

 

The Financing is for a period of 30 years, with the Distribution payable to Duke throughout the duration of this term, unless Tristone utilises an early buyback option which will trigger an early redemption payment to Duke.

 

Duke will also receive a 17.5% equity stake in the business as part of the transaction.

 

Duke Royalty Portfolio

 

A full list of Duke's current Royalty Partners are now included for reference on the Partners page of the Company's website: www.dukeroyalty.com/partners

 

This announcement contains inside information.

 

***ENDS***

 

 

For further information, please visit www.dukeroyalty.com or contact:

 

Duke Royalty Limited

Neil Johnson / Charlie Cannon Brookes / Hugo Evans

 

+44 (0) 1481 730 613

Cenkos Securities plc 

(Nominated Adviser

and Joint Broker)

Stephen Keys / Callum Davidson / Julian Morse / Michael Johnson

+44 (0) 207 397 8900

 

 

 

Canaccord Genuity

(Joint Broker)

 

Adam James / Georgina McCooke

+44 (0) 207 523 8000

SEC Newgate (PR)

Elisabeth Cowell / Richard Bicknell / Megan Kovach

+ +44 (0) 20 3757 6880 dukeroyalty@secnewgate.co.uk

 

About Duke Royalty

 

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRDKPBQKBDBDBD
Date   Source Headline
10th May 20217:00 amRNSTrading Update
20th Apr 20215:22 pmRNSHolding(s) in Company
20th Apr 20215:19 pmRNSHolding(s) in Company
20th Apr 20214:19 pmRNSHolding(s) in Company
19th Apr 202112:30 pmRNSDirector / PCA Dealings
19th Apr 20217:00 amRNSSuccessful Exit of Investment in Royalty Partner
16th Apr 20213:14 pmRNSResult of General Meeting and Issue of Equity
6th Apr 20215:17 pmRNSResult of PrimaryBid Offer and Total Voting Rights
1st Apr 20217:00 amRNSResult of Placing
31st Mar 20214:32 pmRNSPrimaryBid Offer
31st Mar 20214:30 pmRNSPlacing to raise a minimum of £30 million
31st Mar 20214:30 pmRNSExit of Investment into Royalty Partner
18th Mar 20217:00 amRNSIncreased Interim Dividend & Dividend Declaration
15th Mar 20217:00 amRNSIncreased £35 Million Revolving Credit Facility
12th Mar 20217:00 amRNSHolding(s) in Company
10th Mar 20217:00 amRNSHolding(s) in Company
1st Mar 20212:05 pmRNSSecond Price Monitoring Extn
1st Mar 20212:00 pmRNSPrice Monitoring Extension
1st Mar 20217:00 amRNSFollow-on investment into existing royalty partner
19th Feb 20217:00 amRNSHolding(s) in Company
16th Feb 20217:00 amRNSNew Royalty Partner
9th Feb 20212:36 pmRNSHolding(s) in Company
4th Feb 20217:00 amRNSTrading Update
22nd Jan 202111:44 amRNSHolding(s) in Company
14th Jan 20217:00 amRNSFollow-on investment into existing Royalty Partner
11th Jan 20217:00 amRNSAppointment of Chief Investment Officer
24th Dec 20207:00 amRNSFollow-on investment into existing royalty partner
22nd Dec 20207:01 amRNSFollow-on investment into existing royalty partner
22nd Dec 20207:00 amRNSExit of Investment in Royalty Partner
9th Dec 20207:01 amRNSInterim Results
9th Dec 20207:00 amRNSReinstated Cash Dividend and Dividend Declaration
18th Nov 20207:01 amRNSInvestor Presentation
18th Nov 20207:00 amRNSNotice of Interim Results
12th Nov 20209:05 amRNSSecond Price Monitoring Extn
12th Nov 20209:00 amRNSPrice Monitoring Extension
12th Nov 20207:00 amRNSTrading Update and Reinstatement of Cash Dividend
21st Oct 20202:34 pmRNSResult of Annual General Meeting
21st Oct 20207:00 amRNSAppointment of Joint Broker
15th Oct 20205:35 pmRNSHolding(s) in Company
14th Oct 20201:00 pmRNSDirector/PDMR Dealings
2nd Oct 20203:47 pmRNSIssue of Equity for Scrip Dividend
2nd Oct 202012:39 pmRNSLTIP, Issue of Equity, Director/PDMR Holdings
1st Oct 20201:25 pmRNSScrip Dividend Reference Price
25th Sep 20207:00 amRNSPosting of Report and Accounts and Notice of AGM
17th Sep 20207:01 amRNSFinancial 2020 Final Results
17th Sep 20207:00 amRNSDividend Declaration
16th Sep 20207:00 amRNSTrading Update
14th Sep 20207:00 amRNSSuccessful Exit of Investment in Royalty Partner
10th Aug 20207:00 amRNSHolding(s) in Company
10th Aug 20207:00 amRNSFollow-on investment into existing royalty partner

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.